Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11713
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWoodward, Michael Men
dc.date.accessioned2015-05-16T01:19:53Z
dc.date.available2015-05-16T01:19:53Z
dc.date.issued2013-03-25en
dc.identifier.citationInternational Psychogeriatrics / Ipa 2013; 25(6): 877-85en
dc.identifier.govdoc23522497en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/11713en
dc.description.abstractDuring the course of Alzheimer's disease (AD), cognitive processes, including language and communication, become increasingly impaired. The aim of this review was to highlight the impact of communication deficits in AD, and discuss the need for effective treatments.PubMed was searched for studies relating to language and communication in AD. The publications identified were used as a basis for the commentary in this paper. Studies relating to the clinical effectiveness of pharmacological treatment for language and communication issues were identified systematically.Communication deficits are common in AD. From the earliest disease stage, the patient's capacity for communication declines as problems develop with the use of language and all aspects of functional communication. There is a loss of the ability to communicate thoughts and needs, and it becomes increasingly difficult to interact socially and sustain personal relationships with caregivers, family, and friends. It is unsurprising that patients become frustrated at their loss of self-expression, and studies have demonstrated that impaired communication is strongly linked with the development of significant behavioral concerns. Overall, poor communication contributes to caregiver strain, and adds notably to the burden of disease. Clinical data and post-hoc analyses provide preliminary indications that anti-AD therapies (memantine and the cholinesterase inhibitors, ChEIs) and non-pharmacological cognitive-linguistic stimulation techniques may be helpful in addressing communication difficulties.The capacity to treat or slow the progression of communication deficits in AD would prolong patient independence, and have a profound impact on the quality of life of patients and caregivers. The use of pharmacological (anti-AD therapies) and non-pharmacological (cognitive-linguistic stimulation) treatments may be useful management methods and warrant further investigation.en
dc.language.isoenen
dc.subject.otherAlzheimer Disease.complications.drug therapy.psychologyen
dc.subject.otherAntiparkinson Agents.therapeutic useen
dc.subject.otherCaregivers.psychologyen
dc.subject.otherCholinesterase Inhibitors.therapeutic useen
dc.subject.otherCognition Disorders.drug therapy.etiologyen
dc.subject.otherCommunicationen
dc.subject.otherHumansen
dc.subject.otherLanguageen
dc.subject.otherMemantine.therapeutic useen
dc.titleAspects of communication in Alzheimer's disease: clinical features and treatment options.en
dc.typeJournal Articleen
dc.identifier.journaltitleInternational psychogeriatrics / IPAen
dc.identifier.affiliationAged Care Service, Heidelberg Repatriation Hospital, Austin Health, Victoria, Australiaen
dc.identifier.doi10.1017/S1041610213000318en
dc.description.pages877-85en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/23522497en
dc.type.austinJournal Articleen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptAged Care-
crisitem.author.deptGeriatric Medicine-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

16
checked on Feb 5, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.